Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 3, 2009, Pages 329-334

  Kotani, Kazuhiko ^a,b   Sakane, Naoki ^a   Sano, Yoshiko ^a   Tsuzaki, Kokoro ^a   Matsuoka, Yukiyo ^a   Egawa, Kahori ^c   Yoshimura, Makiko ^c   Horikawa, Chika ^c   Kitagawa, Yoshinori ^c   Kiso, Yoshinobu ^c   Kimura, Satoshi ^d   Schulze, John ^e   Taing, Jennifer ^e   Gugliucci, Alejandro ^e  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c SUNTORY LTD   (Japan)

^d SHOWA UNIVERSITY NORTHERN YOKOHAMA HOSPITAL   (Japan)

^e TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

BMI; High density lipoprotein; Low caloric diet; Low density lipoprotein; Weight reduction

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUCONOLACTONASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LOW CALORY DIET; OBESITY; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 70549100902     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-26     Document Type: Article

References (36)

1. Haffner, S.M.: Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity, 14, S121-S127, 2006.
2. Ferretti, G., Bacchetti, T., Moroni, C., Savino, S., Liuzzi, A., Balzola, F., and Bicchiega, V.: Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J. Clin. Endocrinol. Metab., 90, 1728-1733, 2005.
3. Liu, Y., Mackness, B., and Mackness, M.: Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress. Free Radic. Biol. Med., 45, 743-748, 2008.
4. Durrington, P.N., Mackness, B., and Mackness, M.I.: Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 21, 473-480, 2001.
5. Kim, N.S., Kang, K., Cha, M.H., Kang, B.J., Moon, J., Kang, B.K., Yu, B.C., Kim, Y.S., Choi, S.M., and Bang, O.S.: Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. Biochem. Biophys. Res. Commun., 364, 157-162, 2007.
6. Sharma, R., Singh, B., and Mahajan, M.: PON-1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease. Kaohsiung J. Med. Sci., 23, 225-231, 2007.
7. Bhattacharyya, T., Nicholls, S.J., Topol, E.J., Zhang, R., Yang, X., Schmitt, D., Fu, X., Shao, M., Brennan, D.M., Ellis, S.G., Brennan, M.L., Allayee, H., Lusis, A.J., and Hazen, S.L.: Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA, 299, 1265-1276, 2008.
8. Hill, J.O. and Wyatt, H.: Outpatient management of obesity: a primary care perspective. Obes. Res., 2, S124-S130, 2002.
9. Berkel, L.A., Poston, W.S., Reeves, R.S., and Foreyt, J.P.: Behavioral interventions for obesity. J. Am. Diet. Assoc., 105, S35-S43, 2005.
10. Uzun, H., Zengin, K., Taskin, M., Aydin, S., Simsek, G., and Dariyerli, N.: Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes. Surg., 14, 659-665, 2004.
11. Audikovszky, M., Pados, G., Seres, I., Harangi, M., Fülöp, P., Katona, E., Illyés, L., Winkler, G., Katona, E.M., and Paragh, G.: Orlistat increases serum paraoxonase activity in obese patients. Nutr. Metab. Cardiovasc. Dis., 17, 268-273, 2007.
12. Rector, R.S., Warner, S.O., Liu, Y., Hinton, P.S., Sun, G.Y., Cox, R.H., Stump, C.S., Laughlin, M.H., Dellsperger, K.C., and Thomas, T.R.: Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab., 293, E500-E506, 2007.
13. Thompson, P.D., Jeffery, R.W., Wing, R.R., and Wood, P.D.: Unexpected decrease in plasma high density lipoprotein cholesterol with weight loss. Am. J. Clin. Nutr., 32, 2016-2021, 1979.
14. Shoji, T., Nishizawa, Y., Koyama, H., Hagiwara, S., Aratani, H., Izumotani-Sasao, K., Kishimoto, H., Tanishita, H., and Morii, H.: Lipoprotein metabolism in normolipidemic obese women during very low calorie diet: changes in high density lipoprotein. J. Nutr. Sci. Vitaminol., 37, S57-S64, 1991.
15. Cominacini, L., Garbin, U., Davoli, A., Campagnola, M., De Santis, A., Pasini, C., Pastorino, A.M., and Bosello, O.: Influence of weight reduction on plasma high-density-lipoprotein cholesterol concentrations in severe obesity: interrelationships with plasma insulin levels. Ann. Nutr. Metab., 35, 339-346, 1991.
16. Barnard, R.J.: Effects of life-style modification on serum lipids. Arch. Intern. Med., 151, 1389-1394, 1991.
17. Tzotzas, T., Samara, M., Constantinidis, T., Tziomalos, K., and Krassas, G.: Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome. Angiology, 58, 26-33, 2007. (Pubitemid 46272194)
18. Brinton, E.A., Eisenberg, S., and Breslow, J.L.: A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J. Clin. Invest., 85, 144-151, 1990.
19. Katzel, L., Coon, P.J., Dengel, J., and Goldberg, A.P.: Effects of an American Heart Association step I diet and weight loss on lipoprotein lipid levels in obese men with silent myocardial ischemia and reduced high-density lipoprotein cholesterol. Metabolism, 44, 307-314, 1995.
20. Mosinger, B.J.: Human low-density lipoproteins: oxidative modification and its relation to age, gender, menopausal status and cholesterol concentrations. Eur. J. Clin. Chem. Clin. Biochem., 35, 207-214, 1997.
21. Nieman, D.C., Haig, J.L., Fairchild, K.S., De Guia, E.D., Dizon, G.P., and Register, U.D.: Reducing-diet and exercise-training effects on serum lipids and lipoproteins in mildly obese women. Am. J. Clin. Nutr., 52, 640-645, 1990.
22. Wood, P.D.: Physical activity, diet, and health: independent and interactive effects. Med. Sci. Sports Exerc., 26, 838-843, 1994.
23. Yamanouchi, K., Shinozaki, T., Chikada, K., Nishikawa, T., Ito, K., Shimizu, S., Ozawa, N., Suzuki, Y., Maeno, H., Kato, K., Oshida, Y., and Sato, Y.: Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care, 18, 775-778, 1995.
24. Nikolaidis, M.G. and Mougios, V.: Effects of exercise on the fatty-acid composition of blood and tissue lipids. Sports Med., 34, 1051-1076, 2004.
25. Khersonsky, O. and Tawfik, D.S.: The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J. Biol. Chem., 281, 7649-7656, 2006.
26. Khersonsky, O. and Tawfik, D.S.: Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases. Chembiochem, 7, 49-53, 2006. (Pubitemid 43076285)
27. Zimmerman, J., Kaufmann, N.A., Fainaru, M., Eisenberg, S., Oschry, Y., Friedlander, Y., and Stein, Y.: Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Atherosclerosis, 4, 115-123, 1984. (Pubitemid 14152889)
28. Mackness, M.I., Durrington, P.N., and Mackness, B.: The role of paraoxonase 1 activity in cardiovascular disease: potencial for therapeutic intervention. Am. J. Cardiovasc. Drugs, 4, 211-217, 2004.
29. Aviram, M. and Rosenblat, M.: Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr. Opin. Lipidol., 16, 393-399, 2005.
30. Rantala, M., Silaste, M.L., Tuominen, A., Kaikkonen, J., Salonen, J.T., Alfthan, G., Aro, A., and Kesäniemi, Y.A.: Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women. J. Nutr., 132, 3012-3017, 2002.
31. Domagala, T.B., Lacinski, M., Trzeciak, W.H., Mackness, B., Mackness, M.I., and Jakubowski, H.: The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status. Cell Mol. Biol., 52, 4-10, 2006.
32. Vasankari, T., Fogelholm, M., Kukkonen-Harjula, K., Nenonen, A., Kujala, U., Oja, P., Vuori, I., Pasanen, P., Neuvonen, K., and Ahotupa, M.: Reduced oxidized low-density lipoprotein after weight reduction in obese premenopausal women. Int. J. Obes. Relat. Metab. Disord., 25, 205-211, 2001.
33. Holvoet, P., Lee, D.H., Steffes, M., Gross, M., and Jacobs, D.R. Jr.: Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA, 299, 2287-2293, 2008. (Pubitemid 351724395)
34. Shin, M.J., Hyun, Y.J., Kim, O.Y., Kim, J.Y., Jang, Y., and Lee, J.H.: Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int. J. Obes., 30, 1529-1534, 2006.
35. Roberts, C.K., Ng, C., Hama, S., Eliseo, A.J., and Barnard, R.J.: Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. J. Appl. Physiol., 101, 1727-1732, 2006.
36. Navab, M., Reddy, S., Van Lenten, B.J., Anantharamaiah, G.M., and Fogelman, A.M.: The role of dysfunctional HDL in atherosclerosis. J. Lipid Res., 50, S145-S149, 2009.